Billing Models vs. Reality: What Clinical Trials Actually Need

In clinical research, two dominant billing models tend to square off: unit-based pricing (billing per deliverable, like site visits or patient visits) and time-and-expense (T&E) billing, which charges for actual hours worked and costs incurred. Bill units tend to be preferred by budgeting teams who value predictability and hope that early-stage assumptions will hold. However, even with the most careful estimates, this approach routinely collapses under real-world conditions, where deviations, delays, and protocol drift are the norm. T&E, on the other hand, offers transparency and adaptability, especially for senior freelance talent and FSP teams who operate in fast-paced environments. 

 At OWL, we’ve seen unit-based models backfire again and again: under-scoped budgets, constant re-forecasting, and consultants forced into “do more with less” mode to protect margins, leading to burnout and declining service quality. When paired with clear expectations and senior-level autonomy, the T&E approach is often the more honest and sustainable model for both sides. 

This is why we advocate for FTE-based projections, not just as a pricing strategy, but because it mirrors how work actually gets done. Scoping by role-based capacity encourages more sustainable resourcing decisions, and it places value on human factors like team continuity, morale, and institutional memory. These aren’t soft metrics, they’re the difference between a clinical trial that limps across the finish line and one that runs clean from the start.

If we want higher-quality trials, we can’t keep optimizing only for line items and clean spreadsheets. It’s time to align our billing models with how work really gets done.